← All organizations

Ancora Health

Academic/Hospital

Also known as: Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc. | Ancora Health | Ancora Health B.V.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 19, 2022

Acquired by Novo Nordisk on Aug 30, 2023

Timeline

2020s

Aug 30, 2023
Novo Nordisk— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

anc-501

Recent trials (2)

NCT05439603Lead sponsorPhase 2Sep 19, 2022
NCT05439603Study directorPhase 2Sep 19, 2022

Details

Last known activity: Sep 19, 2022